Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors

Drug and Alcohol Dependence

Volumn 127, Issue 1-3, 2013, Pages 143-149

  Le Marchand, Chloe ^a   Evans, Jennifer ^a   Page, Kimberly ^a   Davidson, Peter J ^b   Hahn, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol; Alcohol dependence; Injecting risk behaviors; Young intravenous drug users

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOL USE DISORDERS TEST CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; UNSAFE SEX;

ADOLESCENT; ADULT; ALCOHOL DRINKING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEEDLE SHARING; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84870902669     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.06.024     Document Type: Article

References (49)

1. Arasteh K., Des Jarlais D.C. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS 2009, 23:657-661.
2. Arasteh K., Des Jarlais D.C. HIV testing and treatment among at-risk drinking injection drug users. J. Int. Assoc. Physicians AIDS Care (Chic.) 2009, 8:196-201.
3. Arasteh K., Des Jarlais D.C., Perlis T.E. Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend. 2008, 95:54-61.
4. AUDIT-C Frequently Asked Questions. United States Department of Veterans Affairs, 2010. Available from: http://www.queri.research.va.gov/tools/alcohol-misuse/alcohol-faqs.cfm.
5. Becker Buxton M., Vlahov D., Strathdee S.A., Des Jarlais D.C., Morse E.V., Ouellet L., Kerndt P., Garfein R.S. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004, 75:177-183.
6. Berham R., Kliegman R., Arvin A., Nelson W. Nelson Textbook of Pediatrics 1996, W.B. Saunders Company, Philadelphia.
7. Bradley K.A., Bush K.R., Epler A.J., Dobie D.J., Davis T.M., Sporleder J.L., Maynard C., Burman M.L., Kivlahan D.R. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch. Intern. Med. 2003, 163:821-829.
8. Bradley K.A., Kivlahan D.R., Williams E.C. Brief approaches to alcohol screening: practical alternatives for primary care. J. Gen. Intern. Med. 2009, 24:881-883.
9. Bush K., Kivlahan D.R., McDonell M.B., Fihn S.D., Bradley K.A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch. Intern. Med. 1998, 158:1789-1795.
10. Campbell J.V., Hagan H., Latka M.H., Garfein R.S., Golub E.T., Coady M.H., Thomas D.L., Strathdee S.A. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006, 81:259-265.
11. Costenbader E.C., Zule W.A., Coomes C.M. The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection. Drug Alcohol Depend. 2007, 89:251-258.
12. Dawson D.A., Grant B.F., Stinson F.S., Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol. Clin. Exp. Res. 2005, 29:844-854.
13. Drumright L.N., Hagan H., Thomas D.L., Latka M.H., Golub E.T., Garfein R.S., Clapp J.D., Campbell J.V., Bonner S., Kapadia F., Thiel T.K., Strathdee S.A. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J. Hepatol. 2011, 55:45-52.
14. Evans J.L., Hahn J.A., Lum P.J., Stein E.S., Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009, 101:152-157.
15. Fuller C.M., Vlahov D., Arria A.M., Ompad D.C., Garfein R., Strathdee S.A. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001, 116(Suppl. 1):136-145.
16. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998, 18(Suppl. 1):S11-S19.
17. Hahn J.A., Evans J.L., Davidson P.J., Lum P.J., Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction 2010, 105:1254-1264.
18. Hahn J.A., Page-Shafer K., Ford J., Paciorek A., Lum P.J. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008, 93:43-50.
19. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 2002, 186:1558-1564.
20. Hahn J.A., Page-Shafer K., Lum P.J., Ochoa K., Moss A.R. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001, 34:180-187.
21. Hahn J.A., Samet J.H. Alcohol and HIV disease progression: weighing the evidence. Curr. HIV/AIDS Rep. 2010, 7:226-233.
22. Howe C.J., Cole S.R., Ostrow D.G., Mehta S.H., Kirk G.D. A prospective study of alcohol consumption and HIV acquisition among injection drug users. AIDS 2011, 25:221-228.
23. Hurley S.F., Jolley D.J., Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997, 349:1797-1800.
24. Jones J., Jones M., Plate C., Lewis D. The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots. Anal. Methods 2011, 3:1101-1106.
25. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001, 357:1397-1401.
26. Kral A.H., Lorvick J., Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune Defic. Syndr. 2000, 24:162-167.
27. Lorvick J., Kral A.H., Seal K., Gee L., Edlin B.R. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am. J. Public Health 2001, 91:46-47.
28. Lucas G.M., Gebo K.A., Chaisson R.E., Moore R.D. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002, 16:767-774.
29. Mackesy-Amiti M.E., Donenberg G.R., Ouellet L.J. Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend. 2012, 124:70-78.
30. Meneses-Gaya C., Zuardi A.W., Loureiro S.R., Hallak J.E., Trzesniak C., de Azevedo Marques J.M., Machado-de-Sousa J.P., Chagas M.H., Souza R.M., Crippa J.A. Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions. Alcohol. Clin. Exp. Res. 2010, 34:1417-1424.
31. Metsch L.R., Pereyra M., Purcell D.W., Latkin C.A., Malow R., Gomez C.A., Latka M.H. Correlates of lending needles/syringes among HIV-seropositive injection drug users. J. Acquir. Immune Defic. Syndr. 2007, 46(Suppl. 2):S72-S79.
32. Morini L., Zucchella A., Polettini A., Politi L., Groppi A. Effect of bleaching on ethyl glucuronide in hair: an in vitro experiment. Forensic Sci. Int. 2010, 198:23-27.
33. Napper L.E., Fisher D.G., Reynolds G.L., Johnson M.E. HIV risk behavior self-report reliability at different recall periods. AIDS Behav. 2010, 14:152-161.
34. Page K., Hahn J.A., Evans J., Shiboski S., Lum P., Delwart E., Tobler L., Andrews W., Avanesyan L., Cooper S. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J. Infect. Dis. 2009, 200:1216.
35. Pol S., Vallet-Pichard A., Corouge M., Mallet V.O. Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contrib. Nephrol. 2012, 176:1-9.
36. Rondinelli A.J., Ouellet L.J., Strathdee S.A., Latka M.H., Hudson S.M., Hagan H., Garfein R.S. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend. 2009, 104:167-174.
37. Rubinsky A.D., Kivlahan D.R., Volk R.J., Maynard C., Bradley K.A. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend. 2010, 108:29-36.
38. Sander P.M., Cole S.R., Ostrow D.G., Mehta S.H., Kirk G.D. Determinants of alcohol consumption in HIV-uninfected injection drug users. Drug Alcohol Depend. 2010, 111:173-176.
39. Shafer K.P., Hahn J.A., Lum P.J., Ochoa K., Graves A., Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J. Acquir. Immune Defic. Syndr. 2002, 31:422-431.
40. Stein M.D., Charuvastra A., Maksad J., Anderson B.J. A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE). Addiction 2002, 97:691-700.
41. Stein M.D., Hanna L., Natarajan R., Clarke J., Marisi M., Sobota M., Rich J. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J. Subst. Abuse Treat. 2000, 18:359-363.
42. Suesse S., Pragst F., Mieczkowski T., Selavka C.M., Elian A., Sachs H., Hastedt M., Rothe M., Campbell J. Practical experiences in application of hair fatty acid ethyl esters and ethyl glucuronide for detection of chronic alcohol abuse in forensic cases. Forensic Sci. Int. 2011, 218:82-91.
43. Suh T., Mandell W., Latkin C., Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug Alcohol Depend. 1997, 47:137-143.
44. Suesse S., Selavka C.M., Mieczkowski T., Pragst F. Fatty acid ethyl ester concentrations in hair and self-reported alcohol consumption in 644 cases from different origin. Forensic Sci. Int. 2010, 196:111-117.
45. Thiede H., Hagan H., Campbell J.V., Strathdee S.A., Bailey S.L., Hudson S.M., Kapadia F., Garfein R.S., Team D.S. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007, 91(Suppl. 1):S39-S47.
46. Thorpe L., Ouellet L., Hershow R., Bailey S., Williams I., Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users, chicago 1997-1999. Ann. Epidemiol. 2000, 10:472-473.
47. United States Government Federal Definition of Homeless 2010, U.S. Department of Housing and Urban Development, Washington, DC.
48. US Government HHS Results from the 2004 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration 2005, US Department of Health and Human Services, Washington, DC.
49. Zule W.A., Costenbader E.C., Coomes C.M., Wechsberg W.M. Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users. Am. J. Public Health 2009, 99(Suppl. 1):S180-S186.